RSV antibody may cut wheezing hospitalizations in toddlers
NCT ID NCT07317141
First seen Jan 06, 2026 · Last updated May 21, 2026 · Updated 12 times
Summary
This study looks at whether giving nirsevimab, a shot that protects against RSV, to babies under 6 months old can reduce wheezing that leads to hospital visits when they are 1-2 years old. Researchers will compare 218,000 children in France who got the shot with those who did not, using health records. The goal is to see if early RSV prevention can lower the risk of asthma-like breathing problems later in childhood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA CHILDHOOD are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospices Civils de Lyon - Hôpital Femme Mère Enfant
Bron, 69677, France
Conditions
Explore the condition pages connected to this study.